PegiHep

COVID-19: Zydus Cadila gets DGCI Nod for Phase 3 Clinical Trials with Biological Therapy

NEW DELHI:Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India…

3 years ago

This website uses cookies.